Advertisement
BHC vs HROW
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BHC is a Hold and HROW is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BHC’s FA Score shows that 0 FA rating(s) are green whileHROW’s FA Score has 1 green FA rating(s).
- BHC’s FA Score: 0 green, 5 red.
- HROW’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BHC’s TA Score shows that 4 TA indicator(s) are bullish while HROW’s TA Score has 5 bullish TA indicator(s).
- BHC’s TA Score: 4 bullish, 5 bearish.
- HROW’s TA Score: 5 bullish, 4 bearish.
Reported Earning Dates
BHC is expected to report earnings on Oct 30, 2025.
HROW is expected to report earnings on Aug 11, 2025.
| BHC | HROW | BHC / HROW | |
| Capitalization | 2.14B | 1.26B | 169% |
| EBITDA | 3B | 18.6M | 16,129% |
| Gain YTD | -28.660 | 2.623 | -1,093% |
| P/E Ratio | 22.12 | N/A | - |
| Revenue | 9.86B | 213M | 4,628% |
| Total Cash | 1.73B | 66.7M | 2,589% |
| Total Debt | 21.7B | 230M | 9,435% |
BHC | HROW | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 80 | 81 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 36 Fair valued | 83 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 50 | |
SMR RATING 1..100 | 100 | 97 | |
PRICE GROWTH RATING 1..100 | 58 | 43 | |
P/E GROWTH RATING 1..100 | 54 | 11 | |
SEASONALITY SCORE 1..100 | 75 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
BHC's Valuation (36) in the Pharmaceuticals Other industry is somewhat better than the same rating for HROW (83). This means that BHC’s stock grew somewhat faster than HROW’s over the last 12 months.
HROW's Profit vs Risk Rating (50) in the Pharmaceuticals Other industry is somewhat better than the same rating for BHC (100). This means that HROW’s stock grew somewhat faster than BHC’s over the last 12 months.
HROW's SMR Rating (97) in the Pharmaceuticals Other industry is in the same range as BHC (100). This means that HROW’s stock grew similarly to BHC’s over the last 12 months.
HROW's Price Growth Rating (43) in the Pharmaceuticals Other industry is in the same range as BHC (58). This means that HROW’s stock grew similarly to BHC’s over the last 12 months.
HROW's P/E Growth Rating (11) in the Pharmaceuticals Other industry is somewhat better than the same rating for BHC (54). This means that HROW’s stock grew somewhat faster than BHC’s over the last 12 months.
| BHC | HROW | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 73% | 3 days ago 84% |
| Stochastic ODDS (%) | 3 days ago 78% | 3 days ago 78% |
| Momentum ODDS (%) | 3 days ago 75% | 3 days ago 70% |
| MACD ODDS (%) | 3 days ago 77% | 3 days ago 77% |
| TrendWeek ODDS (%) | 3 days ago 72% | 3 days ago 80% |
| TrendMonth ODDS (%) | 3 days ago 75% | 3 days ago 83% |
| Advances ODDS (%) | 6 days ago 74% | 3 days ago 84% |
| Declines ODDS (%) | 10 days ago 77% | 10 days ago 81% |
| BollingerBands ODDS (%) | 3 days ago 77% | 3 days ago 79% |
| Aroon ODDS (%) | 3 days ago 77% | 3 days ago 80% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| ASMOX | 20.20 | 0.07 | +0.35% |
| AQR Small Cap Momentum Style I | |||
| TAISX | 13.33 | -0.02 | -0.15% |
| Nuveen Quant Intl Small Cap Eq I | |||
| NBSMX | 49.46 | -0.08 | -0.16% |
| Neuberger Berman Small Cap Growth Instl | |||
| BGEWX | 10.62 | -0.02 | -0.19% |
| Baillie Gifford Emer Mkt Ex Chn Instl | |||
| MGRPX | 70.35 | -0.68 | -0.96% |
| Morgan Stanley Inst Growth R6 | |||
BHC and
Correlation & Price change
A.I.dvisor tells us that BHC and AMPH have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BHC and AMPH's prices will move in lockstep.
| Ticker / NAME | Correlation To BHC | 1D Price Change % | ||
|---|---|---|---|---|
| BHC | 100% | -0.17% | ||
| AMPH - BHC | 27% Poorly correlated | +10.13% | ||
| TEVA - BHC | 26% Poorly correlated | +0.49% | ||
| ZTS - BHC | 26% Poorly correlated | -0.60% | ||
| ELAN - BHC | 25% Poorly correlated | +1.15% | ||
| HROW - BHC | 25% Poorly correlated | +3.67% | ||
More | ||||
HROW and
Correlation & Price change
A.I.dvisor indicates that over the last year, HROW has been loosely correlated with AMRX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if HROW jumps, then AMRX could also see price increases.
| Ticker / NAME | Correlation To HROW | 1D Price Change % | ||
|---|---|---|---|---|
| HROW | 100% | +3.67% | ||
| AMRX - HROW | 46% Loosely correlated | +4.02% | ||
| EBS - HROW | 37% Loosely correlated | +4.00% | ||
| OGI - HROW | 33% Loosely correlated | +2.48% | ||
| AMPH - HROW | 32% Poorly correlated | +10.13% | ||
| VTRS - HROW | 32% Poorly correlated | +3.30% | ||
More | ||||